Arcutis Biotherapeutics, Inc. Insider Trading for February 2021
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Arcutis Biotherapeutics, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Arcutis Biotherapeutics, Inc. for February 2021.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Feb 24 2021 | ARQT | Arcutis Biotherape ... | CHAUDHURI BHASKAR | Director | Sell | S | 35.97 | 2,789 | 100,325 | 881,391 | 884.2 K to 881.4 K (-0.32 %) |
Feb 24 2021 | ARQT | Arcutis Biotherape ... | CHAUDHURI BHASKAR | Director | Sell | S | 35.34 | 7,211 | 254,866 | 884,180 | 891.4 K to 884.2 K (-0.81 %) |
Feb 17 2021 | ARQT | Arcutis Biotherape ... | Welgus Howard G. | Director | Option Exercise | M | 0.58 | 1,222 | 709 | 23,218 | |
Feb 17 2021 | ARQT | Arcutis Biotherape ... | Welgus Howard G. | Director | Option Exercise | M | 1.68 | 1,041 | 1,750 | 26,032 | |
Feb 17 2021 | ARQT | Arcutis Biotherape ... | Welgus Howard G. | Director | Option Exercise | M | 1.68 | 391 | 657 | 11,324 | |
Feb 17 2021 | ARQT | Arcutis Biotherape ... | Welgus Howard G. | Director | Buy | M | 0.58 | 1,222 | 709 | 205,633 | 204.4 K to 205.6 K (+0.60 %) |
Feb 17 2021 | ARQT | Arcutis Biotherape ... | Welgus Howard G. | Director | Buy | M | 1.68 | 1,041 | 1,750 | 204,411 | 203.4 K to 204.4 K (+0.51 %) |
Feb 17 2021 | ARQT | Arcutis Biotherape ... | Welgus Howard G. | Director | Buy | M | 1.68 | 391 | 657 | 203,370 | 203 K to 203.4 K (+0.19 %) |
Feb 12 2021 | ARQT | Arcutis Biotherape ... | Smither John W | Chief Financial Off ... | Option Exercise | M | 1.68 | 750 | 1,260 | 45,482 | |
Feb 12 2021 | ARQT | Arcutis Biotherape ... | Smither John W | Chief Financial Off ... | Sell | S | 35.64 | 2,000 | 71,280 | 87,965 | 90 K to 88 K (-2.22 %) |
Feb 12 2021 | ARQT | Arcutis Biotherape ... | Smither John W | Chief Financial Off ... | Sell | S | 35.64 | 750 | 26,730 | 25,198 | 25.9 K to 25.2 K (-2.89 %) |
Feb 12 2021 | ARQT | Arcutis Biotherape ... | Smither John W | Chief Financial Off ... | Buy | M | 1.68 | 750 | 1,260 | 25,948 | 25.2 K to 25.9 K (+2.98 %) |
Feb 08 2021 | ARQT | Arcutis Biotherape ... | Watanabe Todd Franklin | President and CEO | Option Exercise | M | 1.68 | 10,000 | 16,806 | 135,492 | |
Feb 08 2021 | ARQT | Arcutis Biotherape ... | Watanabe Todd Franklin | President and CEO | Sell | S | 34.61 | 6,700 | 231,898 | 568,323 | 575 K to 568.3 K (-1.17 %) |
Feb 08 2021 | ARQT | Arcutis Biotherape ... | Watanabe Todd Franklin | President and CEO | Sell | S | 33.64 | 3,300 | 111,017 | 575,023 | 578.3 K to 575 K (-0.57 %) |
Feb 08 2021 | ARQT | Arcutis Biotherape ... | Watanabe Todd Franklin | President and CEO | Buy | M | 1.68 | 10,000 | 16,806 | 578,323 | 568.3 K to 578.3 K (+1.76 %) |
Feb 08 2021 | ARQT | Arcutis Biotherape ... | Welgus Howard G. | Director | Option Exercise | M | 1.68 | 17,909 | 30,098 | 27,073 | |
Feb 08 2021 | ARQT | Arcutis Biotherape ... | Welgus Howard G. | Director | Option Exercise | M | 1.68 | 1,952 | 3,281 | 11,715 | |
Feb 08 2021 | ARQT | Arcutis Biotherape ... | Welgus Howard G. | Director | Buy | M | 1.68 | 17,909 | 30,098 | 202,979 | 185.1 K to 203 K (+9.68 %) |
Feb 08 2021 | ARQT | Arcutis Biotherape ... | Welgus Howard G. | Director | Buy | M | 1.68 | 1,952 | 3,281 | 185,070 | 183.1 K to 185.1 K (+1.07 %) |
Feb 03 2021 | ARQT | Arcutis Biotherape ... | Welgus Howard G. | Director | Option Exercise | M | 1.68 | 1,820 | 3,059 | 27,333 | |
Feb 03 2021 | ARQT | Arcutis Biotherape ... | Welgus Howard G. | Director | Option Exercise | M | 1.68 | 380 | 639 | 12,896 | |
Feb 03 2021 | ARQT | Arcutis Biotherape ... | Welgus Howard G. | Director | Sell | S | 36.00 | 50 | 1,800 | 183,118 | 183.2 K to 183.1 K (-0.03 %) |
Feb 03 2021 | ARQT | Arcutis Biotherape ... | Welgus Howard G. | Director | Sell | S | 35.02 | 350 | 12,259 | 183,168 | 183.5 K to 183.2 K (-0.19 %) |
Feb 03 2021 | ARQT | Arcutis Biotherape ... | Welgus Howard G. | Director | Sell | S | 34.49 | 1,250 | 43,114 | 183,518 | 184.8 K to 183.5 K (-0.68 %) |
Feb 03 2021 | ARQT | Arcutis Biotherape ... | Welgus Howard G. | Director | Sell | S | 33.45 | 550 | 18,400 | 184,768 | 185.3 K to 184.8 K (-0.30 %) |
Feb 03 2021 | ARQT | Arcutis Biotherape ... | Welgus Howard G. | Director | Buy | M | 1.68 | 1,820 | 3,059 | 185,318 | 183.5 K to 185.3 K (+0.99 %) |
Feb 03 2021 | ARQT | Arcutis Biotherape ... | Welgus Howard G. | Director | Buy | M | 1.68 | 380 | 639 | 183,498 | 183.1 K to 183.5 K (+0.21 %) |
Feb 03 2021 | ARQT | Arcutis Biotherape ... | Smither John W | Chief Financial Off ... | Option Exercise | M | 1.68 | 1,250 | 2,101 | 46,232 | |
Feb 03 2021 | ARQT | Arcutis Biotherape ... | Smither John W | Chief Financial Off ... | Sell | S | 35.00 | 3,750 | 131,250 | 89,965 | 93.7 K to 90 K (-4.00 %) |
Feb 03 2021 | ARQT | Arcutis Biotherape ... | Smither John W | Chief Financial Off ... | Sell | S | 35.00 | 1,250 | 43,750 | 25,198 | 26.4 K to 25.2 K (-4.73 %) |
Feb 03 2021 | ARQT | Arcutis Biotherape ... | Smither John W | Chief Financial Off ... | Buy | M | 1.68 | 1,250 | 2,101 | 26,448 | 25.2 K to 26.4 K (+4.96 %) |
Feb 02 2021 | ARQT | Arcutis Biotherape ... | CHAUDHURI BHASKAR | Director | Sell | S | 33.25 | 9,949 | 330,804 | 891,391 | 901.3 K to 891.4 K (-1.10 %) |
Feb 02 2021 | ARQT | Arcutis Biotherape ... | CHAUDHURI BHASKAR | Director | Sell | S | 27.50 | 51 | 1,403 | 901,340 | 901.4 K to 901.3 K (-0.01 %) |